Key Market Indicators
Spanish antirheumatic medicine sales are forecast to reach $163.5 million by 2026, a 6% drop from its 2021 figure of $240.9 million. Over the past 12 years, the Spanish market has seen a 4.2% decrease year-on-year. In 2021, Germany topped the ranking with $240.9 million, followed by Spain in second place with $163.5 million, and Canada in fourth with $134.7 million.
